Cargando…

Potential Epigenetic-Based Therapeutic Targets for Glioma

Glioma is characterized by a high recurrence rate, short survival times, high rates of mortality and treatment difficulties. Surgery, chemotherapy and radiation (RT) are the standard treatments, but outcomes rarely improve even after treatment. With the advancement of molecular pathology, recent stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Lanlan, Kondengaden, Shukkoor Muhammed, Che, Fengyuan, Wang, Lijuan, Heng, Xueyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249994/ https://www.ncbi.nlm.nih.gov/pubmed/30498431 http://dx.doi.org/10.3389/fnmol.2018.00408

Ejemplares similares

Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors
por: Zang, Lanlan, et al.
Publicado: (2017)

RAB42 Promotes Glioma Pathogenesis via the VEGF Signaling Pathway
por: Liu, Baoling, et al.
Publicado: (2021)

TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis
por: Che, Fengyuan, et al.
Publicado: (2017)

Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
por: Liu, Baoling, et al.
Publicado: (2022)

Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model
por: Griñán-Ferré, Christian, et al.
Publicado: (2019)

BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
por: Yin, Jiawei, et al.
Publicado: (2019)

Stellera chamaejasme L. extracts in the treatment of glioblastoma cell lines: Biological verification based on a network pharmacology approach
por: Wang, Kaiyue, et al.
Publicado: (2022)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
por: Nalivaeva, Natalia N., et al.
Publicado: (2014)

Modified nodal stage of esophageal cancer based on the evaluation of the hazard rate of the negative and positive lymph node
por: Zhang, Jinling, et al.
Publicado: (2020)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?
por: Cai, Heng, et al.
Publicado: (2020)

DIPG-39. NOVEL PROTEOMIC ANALYSIS REVEALS EPIGENETIC THERAPEUTIC TARGETS IN PEDIATRIC GLIOMA
por: Li, Daphne, et al.
Publicado: (2020)

Hapln2 in Neurological Diseases and Its Potential as Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2019)

Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas
por: Naderlinger, Elisabeth, et al.
Publicado: (2017)

Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke
por: Zhou, Xiangyue, et al.
Publicado: (2021)

Internalized GPCRs as Potential Therapeutic Targets for the Management of Pain
por: Retamal, Jeffri S., et al.
Publicado: (2019)

Identification of potential therapeutic targets for gliomas by bioinformatics analysis
por: Ma, Ke, et al.
Publicado: (2017)

Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020)

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
por: Yu, Kai, et al.
Publicado: (2022)

TIMM44 is a potential therapeutic target of human glioma
por: Guo, Yi-zhuo, et al.
Publicado: (2022)

CDC42—A promising immune-related target in glioma
por: Jiang, Tao, et al.
Publicado: (2023)

Potential Therapeutic Strategies for Intracranial Aneurysms Targeting Aneurysm Pathogenesis
por: Liu, Zhao, et al.
Publicado: (2019)

Long non-coding RNAs: Potential therapeutic targets for epilepsy
por: Liu, Sen, et al.
Publicado: (2022)

Hemisphere-Specific Functional Remodeling and Its Relevance to Tumor Malignancy of Cerebral Glioma Based on Resting-State Functional Network Analysis
por: Cai, Siqi, et al.
Publicado: (2021)

WDR43 is a potential diagnostic biomarker and therapeutic target for osteoarthritis complicated with Parkinson’s disease
por: Heng, Hongquan, et al.
Publicado: (2022)

Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
por: HASHIZUME, Rintaro
Publicado: (2017)

Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
por: Park, Jong-Whi, et al.
Publicado: (2019)

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting
por: Cockle, J V, et al.
Publicado: (2015)

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
por: Han, Sue, et al.
Publicado: (2020)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
por: Zhu, Zhengyang, et al.
Publicado: (2022)

TMIGD2 as a potential therapeutic target in glioma patients
por: Boulhen, Chaimae, et al.
Publicado: (2023)

Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
por: Dong, Tianyu, et al.
Publicado: (2022)

Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease
por: Fernando, Kurukulasooriya Kavindya Madushani, et al.
Publicado: (2021)

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
por: Hu, Di, et al.
Publicado: (2021)

Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets
por: Gao, Yue, et al.
Publicado: (2022)

Impacts of impaired mitochondrial dynamics in hearing loss: Potential therapeutic targets
por: Zou, Tianyuan, et al.
Publicado: (2022)

Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma
por: Zhang, Jinling, et al.
Publicado: (2016)

Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets
por: Lizcano, Fernando, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h8n9lk2vpni16u7nknmqksrvmf